Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

IQV – IQVIA Holdings Inc.

Float Short %

2.72

Margin Of Safety %

54

Put/Call OI Ratio

0.93

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

1.39

Price

165.63

Target Price

236.35

Analyst Recom

1.4

Performance Q

-23.78

Upside

4.4%

Beta

1.41

Ticker: IQV




17 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23IQV235.270.680.674381
2026-01-26IQV239.440.650.864811
2026-01-27IQV241.160.633.295343
2026-01-28IQV239.770.810.326585
2026-01-29IQV235.540.801.286651
2026-01-30IQV230.070.801.046670
2026-02-02IQV231.190.781.316035
2026-02-04IQV202.331.352.708560
2026-02-05IQV180.832.091.4811479
2026-02-06IQV187.531.100.6014116
2026-02-09IQV192.670.930.9013988
2026-02-10IQV182.481.012.3415022
2026-02-11IQV177.161.148.3615908
2026-02-12IQV168.861.436.6618335
2026-02-13IQV166.871.101.2916373
2026-02-18IQV171.031.087.0716598
2026-02-19IQV169.410.932.7415538
DateSymbolLatestP/C OIP/C VolTotal OI
17 items Current Page1 of 1




17 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23IQV235.278.9-63.211.89
2026-01-26IQV239.438.9-6.311.89
2026-01-27IQV241.068.9-24.511.89
2026-01-28IQV239.678.9-45.911.89
2026-01-29IQV235.498.9-66.711.89
2026-01-30IQV229.988.9-77.011.89
2026-02-02IQV231.178.9-28.611.89
2026-02-03IQV203.718.9-238.311.89
2026-02-04IQV202.268.9-48.411.89
2026-02-05IQV180.958.9-211.011.89
2026-02-06IQV187.418.922.311.89
2026-02-09IQV192.688.97.611.89
2026-02-10IQV182.535.0626.712.69
2026-02-12IQV168.855.0641.312.69
2026-02-18IQV170.985.0820.312.69
2026-02-19IQV169.324.9718.312.69
2026-02-20IQV165.634.9- 12.69
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
17 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23IQV-6.19-2.732.21
2026-01-26IQV-5.84-2.522.21
2026-01-27IQV-5.84-2.522.21
2026-01-28IQV-5.84-2.522.47
2026-01-29IQV-5.84-2.522.47
2026-01-30IQV-5.84-2.522.47
2026-02-02IQV-5.84-4.152.47
2026-02-03IQV-5.84-4.152.47
2026-02-04IQV-5.84-4.152.47
2026-02-05IQV-5.84-4.152.47
2026-02-06IQV-5.84-4.152.47
2026-02-09IQV-5.84-3.932.47
2026-02-10IQV-5.84-3.932.47
2026-02-11IQV-5.84-3.932.70
2026-02-12IQV-5.84-3.932.70
2026-02-13IQV-5.84-3.932.70
2026-02-17IQV-5.84-1.472.71
2026-02-18IQV-5.61-1.472.71
2026-02-19IQV-5.61-1.472.71
2026-02-20IQV-5.63-1.472.72
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

2.83

Avg. EPS Est. Next Quarter

3.01

Insider Transactions

-5.63

Institutional Transactions

-1.47

Beta

1.41

Average Sales Estimate Current Quarter

4099

Average Sales Estimate Next Quarter

4247

Fair Value

255.32

Quality Score

68

Growth Score

82

Sentiment Score

53

Actual DrawDown %

42

Max Drawdown 5-Year %

-51.5

Target Price

236.35

P/E

21.08

Forward P/E

11.77

PEG

1.26

P/S

1.72

P/B

4.32

P/Free Cash Flow

13.7

EPS

7.86

Average EPS Est. Cur. Y​

12.69

EPS Next Y. (Est.)

14.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.34

Relative Volume

1.45

Return on Equity vs Sector %

-8.2

Return on Equity vs Industry %

9.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.24

EBIT Estimation

IQVIA Holdings, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 93000
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.
stock quote shares IQV – IQVIA Holdings Inc. Stock Price stock today
news today IQV – IQVIA Holdings Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IQV – IQVIA Holdings Inc. yahoo finance google finance
stock history IQV – IQVIA Holdings Inc. invest stock market
stock prices IQV premarket after hours
ticker IQV fair value insiders trading